Edition:
United States

MEI Pharma Inc (MEIP.OQ)

MEIP.OQ on NASDAQ Stock Exchange Capital Market

2.53USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$2.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
70,803
52-wk High
$5.13
52-wk Low
$1.79

Chart for

About

MEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and ME-401. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the... (more)

Overall

Beta: 1.43
Market Cap(Mil.): $94.93
Shares Outstanding(Mil.): 36.94
Dividend: --
Yield (%): --

Financials

  MEIP.OQ Industry Sector
P/E (TTM): 38.43 69.71 34.39
EPS (TTM): 0.07 -- --
ROI: 5.77 9.01 14.96
ROE: 5.77 10.15 16.52

Earnings vs. Estimates